2 comments
Pasadena-based artificial intelligence developer Deep 6 AI has selected a vice president to head its life sciences division, the company announced Tuesday.
Jason Attanucci will fill the newly created role, in which he will “introduce the Deep 6 AI Clinical Trials Acceleration Software (CTAS) platform to the life sciences eClinical market,” Deep 6 said in a written statement.
He has nearly two decades of experience in the industry and most recently served as global head of customer solutions and senior director of sales and partnerships at the research technology firm BioFortis, according to Deep 6.
“Deep 6 AI is primed for rapid growth in the life sciences eClinical market — and the entire clinical trial ecosystem at large,” Attanucci said. “Deep 6’s ability to precision-match patients to clinical trials, using AI and natural language processing is unparalleled in the industry. I’m thrilled to offer this unique data-driven solution that connects all clinical trial stakeholders, in support of our mission to help bring new treatments to patients, faster.”
Attanucci’s skills and experience represent a valuable resource, Deep 6 CEO Wout Brusselaers said.
“Jason is a great addition to our leadership team,” he said. “His deep understanding of the eClinical market and singular focus on value delivery for our clients will help bring the benefits of Deep 6 AI’s cutting-edge software solution to biopharmaceutical sponsors and contract research organizations around the world.”
More information about Deep 6 AI can be found on the company’s website at deep6.ai.
Get our daily Pasadena newspaper in your email box. Free.
Get all the latest Pasadena news, more than 10 fresh stories daily, 7 days a week at 7 a.m.
